Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;10(2):e002315.
doi: 10.1136/openhrt-2023-002315.

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort

Colinda Van Deutekom  1 , Bastiaan Geelhoed  1 , Barbara C Van Munster  2 , Stephan J L Bakker  3 , Ron T Gansevoort  3 , Isabelle C Van Gelder  1 , Michiel Rienstra  4
Affiliations

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort

Colinda Van Deutekom et al. Open Heart. 2023 Jul.

Abstract

Objective: Atrial fibrillation (AF) is a condition that occurs in the presence of comorbidities. With the accumulation of comorbidities (multimorbidity), some combinations may more often occur together than others. Information on the impact of clustering of these on incident AF is sparse. We aimed to investigate clustering of cardiovascular and renal comorbidities and study the association between comorbidity clusters and incident AF.

Methods: We used the community-based Prevention of Renal and Vascular ENd-stage Disease (PREVEND) cohort in which 8592 individuals participated. Latent class analysis was performed to assess clustering of 10 cardiovascular and renal comorbidities.

Results: We excluded individuals with prior AF or missing ECG data, leaving 8265 individuals for analysis (mean age 48.9±12.6 years, 50.2% women). During 9.2±2.1 years of follow-up, 251 individuals (3.0%) developed AF. A model with three clusters was the optimal model, with one cluster being young (44.5±10.8 years) and healthy, carrying a low (1.0%) risk of incident AF; one cluster being older (63.0±8.4 years) and multimorbid, carrying a high (16.2%) risk of incident AF and a third middle-aged (57.0±11.3 years), obese and hypertensive cluster carrying an intermediate risk (5.9%) of incident AF. While the prevalence of the comorbidities differed between classes, no clear combination(s) of comorbidities was observed within the classes.

Conclusions: We identified three clusters of comorbidities in individuals in the community-based PREVEND cohort. The three clusters contained different amount of comorbidities carrying different risks of incident AF. However, there were no differences between the clusters regarding specific combination(s) of comorbidities.

Keywords: Atrial Fibrillation; EPIDEMIOLOGY; RISK FACTORS.

PubMed Disclaimer

Conflict of interest statement

Competing interests: For the current manuscript, the authors declare no potential conflicts of interest. Outside of the submitted work, the authors disclosed the following financial support: MR reports grants from the Dutch Heart Foundation (CVON RACE V, grant 2014-09; CVON RED-CVD, grant 2017-11; CVON-AI, grant 2018B017; DECISION, grant 2018B024). The UMCG, which employs MR, has received grants from SJM/Abbott (VIP-HF study) and Medtronic (Cryoballoon AF registry/biobank study). ICVG reports grants from the Dutch Heart Foundation (CVON RACE V, grant 2014-09).

Figures

Figure 1
Figure 1
Distribution of the number of comorbidities: upper panel: total population; lower panel: divided by latent classes. AF, atrial fibrillation.
Figure 2
Figure 2
Heat map of individual cardiovascular and renal comorbidities within each cluster the colours represent the log relative risk of the presence of the comorbidity compared with the average individual in this cohort. The branching diagrams represent the hierarchy of categories based on degree of similarity between the comorbidities (rows) or clusters (columns).
Figure 3
Figure 3
Cumulative probability of incident AF by comorbidity cluster. AF, atrial fibrillation.
See this image and copyright information in PMC

References

    1. Jani BD, Nicholl BI, McQueenie R, et al. . Multimorbidity and Co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. Europace 2018;20(FI_3):f329–36. 10.1093/europace/eux322 - DOI - PMC - PubMed
    1. Benjamin EJ, Levy D, Vaziri SM, et al. . Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study. JAMA 1994;271:840–4. - PubMed
    1. Lee S-R, Park CS, Choi E-K, et al. . Hypertension burden and the risk of new-onset atrial fibrillation: A nationwide population-based study. Hypertension 2021;77:919–28. 10.1161/HYPERTENSIONAHA.120.16659 - DOI - PubMed
    1. Ninni S, Lemesle G, Meurice T, et al. . Real-life incident atrial fibrillation in outpatients with coronary artery disease. J Clin Med 2020;9. 10.3390/jcm9082367 - DOI - PMC - PubMed
    1. Sharashova E, Wilsgaard T, Ball J, et al. . Long-term blood pressure Trajectories and incident atrial fibrillation in women and men: the Tromsø study. Eur Heart J 2020;41:1554–62. 10.1093/eurheartj/ehz234 - DOI - PMC - PubMed

Publication types